ロード中...

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens

BACKGROUND: Etravirine (ETR), a non-nucleoside reverse transcriptase inhibitor (NNRTI) available in France since 2006, is indicated for antiretroviral-experienced HIV-infected adults, in combination with a ritonavir-boosted protease inhibitor (PI). To assess its clinical impact in routine care, we c...

詳細記述

保存先:
書誌詳細
出版年:BMC Infect Dis
主要な著者: Potard, Valérie, Goujard, Cécile, Valantin, Marc Antoine, Lacombe, Jean Marc, Lahoulou, Rima, Chéret, Arnaud, Girard, Pierre Marie, Costagliola, Dominique
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6042265/
https://ncbi.nlm.nih.gov/pubmed/29996784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3231-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!